Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1371/journal.pone.0199160

http://scihub22266oqcxt.onion/10.1371/journal.pone.0199160
suck pdf from google scholar
29969455!6029762!29969455
unlimited free pdf from europmc29969455    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid29969455      PLoS+One 2018 ; 13 (7): e0199160
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis #MMPMID29969455
  • Okamoto T; Hatakeyama S; Hosogoe S; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
  • PLoS One 2018[]; 13 (7): e0199160 PMID29969455show ga
  • BACKGROUNDS: Proton pump inhibitors (PPIs) can be associated with vascular calcification in patients undergoing dialysis through hypomagnesemia. However, only few studies have demonstrated the influence of PPIs on vascular calcification in patients on maintenance hemodialysis (HD). This study aimed to investigate whether the use of PPIs accelerates vascular calcification in patients on HD. MATERIALS AND METHODS: We retrospectively evaluated 200 HD patients who underwent regular blood tests and computed tomography (CT) between 2016 and 2017. The abdominal aortic calcification index (ACI) was measured using abdominal CT. The difference in the ACI values between 2016 and 2017 was evaluated as DeltaACI. Patients were divided into PPI and non-PPI groups, and variables, such as patient background, medication, laboratory data, and DeltaACI were compared. Factors independently associated with higher DeltaACI progression (>/= third tertile value of DeltaACI in this study) were determined using multivariate logistic regression analysis. RESULTS: The PPI and non-PPI groups had 112 (56%) and 88 (44%) patients, respectively. Median and third tertile value of DeltaACIs were 4.2% and 5.8%, respectively. Serum magnesium was significantly lower in the PPI (2.1 mg/dL) than in the non-PPI (2.3 mg/dL) group (P <0.001). Median DeltaACI was significantly higher in the PPI (5.0%) than in the non-PPI (3.8%) group (P = 0.009). A total of 77 (39%) patients had a higher DeltaACI. Multivariate analysis revealed that PPIs (odds ratio = 2.23; 95% confidence interval = 1.11-4.49), annual mean calcium phosphorus product, ACI in 2016, baseline serum magnesium levels, and HD vintage were independent factors associated with higher DeltaACI progression after adjusting for confounders. CONCLUSION: PPI use may accelerate vascular calcification in patients on HD. Further studies are necessary to elucidate their influence on vascular calcification.
  • |*Renal Dialysis[MESH]
  • |Aged[MESH]
  • |Aorta, Abdominal/diagnostic imaging/metabolism/pathology[MESH]
  • |Computed Tomography Angiography[MESH]
  • |Disease Progression[MESH]
  • |Esomeprazole/administration & dosage/adverse effects[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Kidney Failure, Chronic/blood/physiopathology/therapy[MESH]
  • |Lansoprazole/administration & dosage/adverse effects[MESH]
  • |Logistic Models[MESH]
  • |Magnesium/*blood[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Omeprazole/administration & dosage/adverse effects[MESH]
  • |Proton Pump Inhibitors/administration & dosage/*adverse effects[MESH]
  • |Rabeprazole/administration & dosage/adverse effects[MESH]
  • |Retrospective Studies[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box